-
Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK − Presentations Include New Data from the TAK-861-2001 Phase 2b Trial in Narcolepsy Type 1 Highlighting Impact on Daily Functioning Including Cognition and Sleep Quality − Data from Long-Term Exte...资讯2024-09-20
最热
推荐
- Matterport Fall 2024 Release: 'Insights Meets Imagination'Elevates the Platform With Gener
- LambdaTest Launches Screen Reader for Enhanced Accessibility Testing on Android Devices
- 中国建材门户网:打造建材行业新标杆,引领未来建筑新风尚
- 湖南广告安装服务:为您的品牌传递强大信息
- 星聚合力 创赢未来|长寿花第七届全国经销商大会暨营销精英颁奖盛典圆满成功
- BOOS Wallet:全球领先的Web3钱包解决方案,虚拟货币去中心化
- 心化物象·随物赋形——艺术名家吴昌伟百家媒体聚焦报道
- 第八届丝绸之路金色年华全国风采大赛暨国潮华服时装周圆满落幕
- 科技与人文的未来交汇:重返未来2024思想会即将启幕
- Canva将收购生成式人工智能平台Leonardo.AI,为所有组织带来领先的视觉人工智能技术